Immunotherapy enables treatment of solid cancerous tumours
University of Calgary researchers have developed a first-in-class CAR T-cell therapy that trains the immune system to target and kill cancer cells.
Welcome to the Arnie Charbonneau Cancer Institute
The Arnie Charbonneau Cancer Institute is a partnership between the University of Calgary and Alberta Health Services, bringing together scientists and clinicians to integrate research and care cross disciplines – from understanding and preventing cancer, to transforming its detection and treatment, to improving life with and after cancer.
Learn more about the past, present, and future of cancer research at the Charbonneau
Need to get in touch? Connect with us
In the News
New immunotherapy developed at the University of Calgary being used to treat solid cancerous tumours
Calgary man says a clinical trial gave him hope when he had none
Tyler Williamson renewed as director of the Centre for Health Informatics
Renewal of five-year term effective July 1, 2026
UCalgary study tears off colon cancer’s invisibility cloak
Research shows removing a single gene makes cancerous cells a target for immunotherapy
Big dreams at a little university: 60 years of the Cumming School of Medicine
Medical education at UCalgary a vital part of its history
UCalgary’s 2026 Three Minute Thesis competition returns with powerful research stories
The Faculty of Graduate Studies brought together top presenters to share their work in three minutes, focusing on clarity, storytelling and public understanding
International study led by UCalgary explores why multiple myeloma patients often relapse after immunotherapy
Understanding how tumour cells build resistance to treatment may impact future individualized cancer care
